DENALI THERAPEUTICS INC
DNLINASDAQ🏆 #1225 by market capEarnings Nov 4US Equity
$351.82▲ $12.00 (+3.41%)
Simulated price1h—
24h▲ 3.4%
7d▲ 1338.6%
14d▲ 1375.4%
30d▲ 1228.4%
1y▲ 2559.3%
🏦Market Cap
$3.95B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
1095.1x
Expensive
Otter Score
58
Weak
Trading Snapshot
- Day Range
- $347.16 – $357.00
- 52-Week Range
- $12.58 – $27.30
- Volume
- $2.33B
- Avg Volume
- $3.03B
- Shares Outstanding
- 158.7M
- Next Earnings
- Oct 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $4M
- Last Q Revenue
- $1M
- P/E Ratio
- —
- P/S Ratio
- 1095.1x
- EPS (TTM)
- $-2.84
- Dividend Yield
- —
Why Investors Own DNLI
- ✓High-growth profile — revenue up +37.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 72% gross margin and 25% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$4M▲ +39.7% YoY
Gross Margin (TTM)
72.2%▲ +2.4% YoY
Operating Income (TTM)
$1M▲ +39.7% YoY
Free Cash Flow (TTM)
$893,792▲ +39.7% YoY
About DENALI THERAPEUTICS INC
A company profile for DENALI THERAPEUTICS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
58/100
Analyst Price Target
ⓘAverage Target
$399.77
▲ +13.6% Upside
High Target$473.78
Low Target$312.08
Based on 35 analysts
Latest News & Updates
🚀
Reuters·2h ago
DENALI THERAPEUTICS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift DNLI price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
DENALI THERAPEUTICS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.